Tue Nov 24 · 14:00 UTC · Seminarmeta-analysis
Good Practices on the Evaluation of Surrogate Endpoints for Health Technology Assessment Decision Making from the ISPOR Taskforce
Oriana Ciani, Dawn Lee · Bocconi University · Online
Surrogate endpoints now underpin around 60% of new FDA drug and biologic approvals of the past two decades, yet their validation is often weak, leaving health technology assessment agencies and payers to decide under considerable uncertainty. Oriana Ciani and Dawn Lee, co-authors of the ISPOR Good Practices Task Force report, present its recommendations: the three levels of evidence for surrogacy…